Arthritis and rheumatism

publication venue for

Chronic polyarthritis associated with hypogammaglobulinemia. A study of two patients. 1977
Systemic lupus erythematosus associated with klinefelter's syndrome. 1977
Absent factor II in systemic lupus erythematosus. Immunologic studies and response to corticosteroid therapy. 1976
Ethical challenges in rheumatology: a survey of the American College of Rheumatology membership.. 65. 2013
Association of granulomatosis with polyangiitis (Wegener's) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysis.. 65. 2013
Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis.. 65. 2013
Interferon-α induction and detection of anti-ro, anti-la, anti-sm, and anti-rnp autoantibodies by autoantigen microarray analysis in juvenile dermatomyositis.. 65. 2013
Long-term safety and efficacy of rilonacept in patients with systemic juvenile idiopathic arthritis.. 65. 2013
Somatic hypermutations confer rheumatoid factor activity in hepatitis C virus-associated mixed cryoglobulinemia.. 65. 2013
Validation of the methotrexate-first strategy in patients with early, poor-prognosis rheumatoid arthritis: results from a two-year randomized, double-blind trial.. 65. 2013
Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial.. 65. 2013
Enhanced rho-associated protein kinase activation in patients with systemic lupus erythematosus.. 65. 2013
In vivo cyclic compression causes cartilage degeneration and subchondral bone changes in mouse tibiae.. 65. 2013
Willingness and access to joint replacement among African American patients with knee osteoarthritis: a randomized, controlled intervention.. 65. 2013
Proteomic analysis of synovial fluid from the osteoarthritic knee: comparison with transcriptome analyses of joint tissues.. 65. 2013
Tumor necrosis factor α induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts.. 65. 2013
Loss of methylation in CpG sites in the NF-κB enhancer elements of inducible nitric oxide synthase is responsible for gene induction in human articular chondrocytes.. 65. 2013
A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome.. 65. 2013
Valgus malalignment is a risk factor for lateral knee osteoarthritis incidence and progression: findings from the Multicenter Osteoarthritis Study and the Osteoarthritis Initiative.. 65. 2013
Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus.. 64. 2012
Regulation of inflammatory responses in tumor necrosis factor-activated and rheumatoid arthritis synovial macrophages by JAK inhibitors.. 64. 2012
Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus.. 64. 2012
Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations.. 64. 2012
Brief Report: IRF5 systemic lupus erythematosus risk haplotype is associated with asymptomatic serologic autoimmunity and progression to clinical autoimmunity in mothers of children with neonatal lupus.. 64. 2012
The interferon signature and STAT1 expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor α and counter-regulated by the synovial fluid microenvironment.. 64. 2012
A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial.. 64. 2012
Large-scale analysis of tumor necrosis factor α levels in systemic lupus erythematosus.. 64. 2012
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.. 64. 2012
Dual regulation of metalloproteinase expression in chondrocytes by Wnt-1-inducible signaling pathway protein 3/CCN6.. 64. 2012
Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies.. 64. 2012
Synovial fluid from patients with early osteoarthritis modulates fibroblast-like synoviocyte responses to toll-like receptor 4 and toll-like receptor 2 ligands via soluble CD14.. 64. 2012
Association of single-nucleotide polymorphisms in CCR6, TAGAP, and TNFAIP3 with rheumatoid arthritis in African Americans.. 64. 2012
Impact of interactions of cigarette smoking with NAT2 polymorphisms on rheumatoid arthritis risk in African Americans.. 64. 2012
Evidence for gene-gene epistatic interactions among susceptibility loci for systemic lupus erythematosus.. 64. 2012
Evaluation of TRAF6 in a large multiancestral lupus cohort.. 64. 2012
Association of N-terminal pro-brain natriuretic peptide with cardiac disease, but not with vascular disease, in systemic lupus erythematosus.. 64. 2012
B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels.. 63. 2011
Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitis.. 63. 2011
Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus.. 63. 2011
Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment.. 63. 2011
Cellular response to prosthetic wear debris differs in patients with and without rheumatoid arthritis.. 64. 2011
Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study.. 63. 2011
Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps.. 64. 2011
HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype.. 64. 2011
Recommendations for publication of genetic association studies in Arthritis & Rheumatism.. 63. 2011
Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups.. 63. 2011
Engraftment of peripheral blood mononuclear cells from systemic lupus erythematosus and antiphospholipid syndrome patient donors into BALB-RAG-2-/- IL-2Rγ-/- mice: a promising model for studying human disease.. 63. 2011
Dose escalation of certolizumab pegol from 200 mg to 400 mg every other week provides no additional efficacy in rheumatoid arthritis: an analysis of individual patient-level data.. 63. 2011
Hospital volume and surgical outcomes after elective hip/knee arthroplasty: a risk-adjusted analysis of a large regional database.. 63. 2011
Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features.. 63. 2011
Solid malignancies among etanercept-treated patients with granulomatosis with polyangiitis (Wegener's): long-term followup of a multicenter longitudinal cohort.. 63. 2011
Hypoxia activates the notch signaling pathway in cells of the intervertebral disc: implications in degenerative disc disease.. 63. 2011
Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus.. 63. 2011
Synovial inflammation in patients undergoing arthroscopic meniscectomy: molecular characterization and relationship to symptoms.. 63. 2011
Systemic lupus erythematosus monocytes are less responsive to interleukin-10 in the presence of immune complexes.. 63. 2011
Alpha₁-antitrypsin deficiency-related alleles Z and S and the risk of Wegener's granulomatosis.. 62. 2010
Associations of cigarette smoking with rheumatoid arthritis in African Americans.. 62. 2010
Most common single-nucleotide polymorphisms associated with rheumatoid arthritis in persons of European ancestry confer risk of rheumatoid arthritis in African Americans.. 62. 2010
Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients.. 62. 2010
A functional RANKL polymorphism associated with younger age at onset of rheumatoid arthritis.. 62. 2010
Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells.. 62. 2010
Generalized bone loss as a predictor of three-year radiographic damage in African American patients with recent-onset rheumatoid arthritis.. 62. 2010
Indocyanine green-enhanced imaging of antigen-induced arthritis with an integrated optical imaging/radiography system.. 62. 2010
Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy.. 62. 2010
Relationship of asymmetric dimethylarginine and homocysteine to vascular aging in systemic lupus erythematosus patients.. 62. 2010
Trefoil factor 3 is induced during degenerative and inflammatory joint disease, activates matrix metalloproteinases, and enhances apoptosis of articular cartilage chondrocytes.. 62. 2010
Association of the response to tumor necrosis factor antagonists with plasma type I interferon activity and interferon-beta/alpha ratios in rheumatoid arthritis patients: a post hoc analysis of a predominantly Hispanic cohort.. 62. 2010
Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients.. 62. 2010
Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling.. 62. 2010
Systemic sclerosis and lupus: points in an interferon-mediated continuum.. 62. 2010
The New York City Rheumatology Objective Structured Clinical Examination: five-year data demonstrates its validity, usefulness as a unique rating tool, objectivity, and sensitivity to change.. 61. 2009
Medical decision making in patients with knee pain, meniscal tear, and osteoarthritis.. 61. 2009
Classification, presentation, and initial treatment of Wegener's granulomatosis in childhood.. 60. 2009
DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytes.. 60. 2009
Skeletal health among African Americans with recent-onset rheumatoid arthritis.. 61. 2009
Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity.. 60. 2009
Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy.. 60. 2009
CTLA4/ICOS gene variants and haplotypes are associated with rheumatoid arthritis and primary biliary cirrhosis in the Canadian population.. 60. 2009
A quality indicator set for systemic lupus erythematosus.. 61. 2009
Rheumatology fellows' perception on training and careers in academia: the American College of Rheumatology Fellow Research and Academic Training Survey.. 61. 2009
Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction.. 60. 2009
Cited2 modulates hypoxia-inducible factor-dependent expression of vascular endothelial growth factor in nucleus pulposus cells of the rat intervertebral disc.. 58. 2008
Correlation of clinical and virologic responses to antiviral treatment and regulatory T cell evolution in patients with hepatitis C virus-induced mixed cryoglobulinemia vasculitis.. 58. 2008
The PTPN22 C1858T polymorphism is associated with skewing of cytokine profiles toward high interferon-alpha activity and low tumor necrosis factor alpha levels in patients with lupus.. 58. 2008
Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients.. 58. 2008
Age- and sex-related patterns of serum interferon-alpha activity in lupus families.. 58. 2008
Differential expression of GADD45beta in normal and osteoarthritic cartilage: potential role in homeostasis of articular chondrocytes.. 58. 2008
Assessment of the item selection and weighting in the Birmingham vasculitis activity score for Wegener's granulomatosis.. 59. 2008
A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase disease.. 58. 2008
Effects of glucocorticoids on weight change during the treatment of Wegener's granulomatosis.. 59. 2008
Racial differences in expectations of joint replacement surgery outcomes.. 59. 2008
Infliximab treatment shifts the balance between stimulatory and inhibitory Fcgamma receptor type II isoforms on neutrophils in patients with rheumatoid arthritis.. 58. 2008
Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.. 58. 2008
Serum type I interferon activity is dependent on maternal diagnosis in anti-SSA/Ro-positive mothers of children with neonatal lupus.. 58. 2008
The HLA-DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixture.. 58. 2008
The development of anticytokine therapeutics for rheumatic diseases.. 58. 2008
Augmented interferon-alpha pathway activation in patients with Sjögren's syndrome treated with etanercept.. 56. 2007
Multicenter validation of a new quality of life measure in pediatric lupus.. 57. 2007
Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus.. 56. 2007
Clinical and genetic risk factors for pneumonia in systemic lupus erythematosus.. 56. 2007
Increased expression of the collagen receptor discoidin domain receptor 2 in articular cartilage as a key event in the pathogenesis of osteoarthritis.. 56. 2007
Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals.. 56. 2007
Assessment of American College of Rheumatology quality criteria for rheumatoid arthritis in a pre-quality criteria patient cohort.. 57. 2007
Comparison of energy expenditure from lifestyle physical activities between patients with rheumatoid arthritis and healthy controls.. 57. 2007
Development of a decision aid to address racial disparities in utilization of knee replacement surgery.. 57. 2007
Application of explicit process of care measurement to rheumatoid arthritis: Moving from evidence to practice.. 55. 2006
Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus.. 54. 2006
Rheumatoid arthritis association with the FCRL3 -169C polymorphism is restricted to PTPN22 1858T-homozygous individuals in a Canadian population.. 54. 2006
Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in African Americans with early rheumatoid arthritis.. 54. 2006
Dysregulation of interleukin-10-dependent gene expression in rheumatoid arthritis synovial macrophages.. 54. 2006
Insulin-like growth factor binding protein 5 induces skin fibrosis: A novel murine model for dermal fibrosis.. 54. 2006
Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus.. 54. 2006
Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients.. 54. 2006
Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus.. 54. 2006
Use of computerized assessment to predict neuropsychological functioning and emotional distress in patients with systemic lupus erythematosus.. 55. 2006
Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies.. 54. 2006
Quality of osteoarthritis care for community-dwelling older adults.. 55. 2006
Longitudinal study of negative workplace events among employed rheumatoid arthritis patients and healthy controls.. 53. 2005
Racial disparity in knee arthroplasty utilization in the veterans health administration.. 53. 2005
Racial/ethnic differences in surgical outcomes in veterans following knee or hip arthroplasty.. 52. 2005
Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia.. 53. 2005
Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).. 52. 2005
Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia.. 52. 2005
Human beta-defensin 3 mediates tissue remodeling processes in articular cartilage by increasing levels of metalloproteinases and reducing levels of their endogenous inhibitors.. 52. 2005
Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.. 52. 2005
Homeostatic effects of the metalloproteinase disintegrin ADAM15 in degenerative cartilage remodeling.. 52. 2005
A serum proteomic approach to gauging the state of remission in Wegener's granulomatosis.. 52. 2005
Evidence for two phenotypes in the metabolism of methotrexate to 7-hydroxymethotrexate in patients with rheumatoid arthritis.. 52. 2005
Mature dendritic cells readily break tolerance in normal mice but do not lead to disease expression.. 52. 2005
Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus.. 50. 2004
Production of endogenous antibiotics in articular cartilage.. 50. 2004
The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept.. 50. 2004
Up-regulation of microsomal prostaglandin E synthase 1 in osteoarthritic human cartilage: critical roles of the ERK-1/2 and p38 signaling pathways.. 50. 2004
Measuring quality in arthritis care: methods for developing the Arthritis Foundation's quality indicator set.. 51. 2004
A pilot study of the use of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography to assess the distribution of activated lymphocytes in patients with systemic lupus erythematosus.. 50. 2004
Measuring systemic lupus erythematosus activity during pregnancy: validation of the lupus activity index in pregnancy scale.. 51. 2004
Religious and nonreligious coping methods among persons with rheumatoid arthritis.. 51. 2004
WISP3-dependent regulation of type II collagen and aggrecan production in chondrocytes.. 50. 2004
Genomic absence of the gene encoding T cell receptor Vbeta7.2 is linked to the presence of autoantibodies in Sjögren's syndrome.. 50. 2004
Domains of health-related quality of life important to patients with giant cell arteritis.. 49. 2003
Molecular phenotyping of human chondrocyte cell lines T/C-28a2, T/C-28a4, and C-28/I2.. 48. 2003
Coffee consumption and risk of rheumatoid arthritis.. 48. 2003
Comparing the efficacy of cyclooxygenase 2-specific inhibitors in treating osteoarthritis: appropriate trial design considerations and results of a randomized, placebo-controlled trial.. 48. 2003
Monitoring by rheumatologists for methotrexate-, etanercept-, infliximab-, and anakinra-associated adverse events.. 48. 2003
Reduction of atherosclerosis in low-density lipoprotein receptor-deficient mice by passive administration of antiphospholipid antibody.. 48. 2003
Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies.. 48. 2003
Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis.. 48. 2003
Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1.. 48. 2003
Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families.. 48. 2003
Intraarticular corticosteroids, supervised physiotherapy, or a combination of the two in the treatment of adhesive capsulitis of the shoulder: a placebo-controlled trial.. 48. 2003
Identification of IgG subclasses and C-reactive protein in lupus nephritis: the relationship between the composition of immune deposits and FCgamma receptor type IIA alleles.. 48. 2003
Synergistic induction of nitric oxide synthase type II: in vitro effect of leptin and interferon-gamma in human chondrocytes and ATDC5 chondrogenic cells.. 48. 2003
Identification of an IL1A gene segment that determines aberrant constitutive expression of interleukin-1 alpha in systemic sclerosis.. 48. 2003
Differences in expectations of outcome mediate African American/white patient differences in "willingness" to consider joint replacement.. 46. 2002
Reduced susceptibility to collagen-induced arthritis in DBA/1J mice expressing the TSG-6 transgene.. 46. 2002
Genetic linkage and association of Fcgamma receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus.. 46. 2002
Light-activated gene transduction enhances adeno-associated virus vector-mediated gene expression in human articular chondrocytes.. 46. 2002
Racial differences in social network experience and perceptions of benefit of arthritis treatments among New York City Medicare beneficiaries with self-reported hip and knee pain.. 47. 2002
Single-nucleotide polymorphisms in tumor necrosis factor receptor genes: definition of novel haplotypes and racial/ethnic differences.. 46. 2002
Physician treatment preferences in rheumatoid arthritis of differing disease severity and activity: the impact of cost on first-line therapy.. 47. 2002
Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.. 46. 2002
Expression of recombination-activating genes and terminal deoxynucleotidyl transferase and secondary rearrangement of immunoglobulin kappa light chains in rheumatoid arthritis synovial tissue.. 44. 2001
Highly enhanced expression of the disintegrin metalloproteinase MDC15 (metargidin) in rheumatoid synovial tissue.. 44. 2001
Rheumatology patient and physician concordance with respect to important health and symptom status outcomes.. 45. 2001
Variation in perceptions of treatment and self-care practices in elderly with osteoarthritis: a comparison between African American and white patients.. 45. 2001
High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin.. 44. 2001
Intercellular adhesion molecule 1 expression is required for antiphospholipid antibody-induced pregnancy loss.. 44. 2001
A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS).. 44. 2001
Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype.. 44. 2001
Low-binding alleles of Fcgamma receptor types IIA and IIIA are inherited independently and are associated with systemic lupus erythematosus in Hispanic patients.. 44. 2001
Amelioration of collagen-induced arthritis in DBA/1J mice by recombinant TSG-6, a tumor necrosis factor/interleukin-1-inducible protein.. 43. 2000
Immortalized human adult articular chondrocytes maintain cartilage-specific phenotype and responses to interleukin-1beta.. 43. 2000
Localization of a gene for familial recurrent arthritis.. 43. 2000
Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome.. 43. 2000
Validation of the Sapporo criteria for antiphospholipid syndrome.. 43. 2000
Staphylococcus aureus stimulates inducible nitric oxide synthase in articular cartilage.. 42. 1999
Differential mechanisms of inorganic pyrophosphate production by plasma cell membrane glycoprotein-1 and B10 in chondrocytes.. 42. 1999
Lower prevalence of Chlamydia pneumoniae DNA compared with Chlamydia trachomatis DNA in synovial tissue of arthritis patients.. 42. 1999
Up-regulation of MDC15 (metargidin) messenger RNA in human osteoarthritic cartilage.. 42. 1999
A role for the polymorphism at position 247 of the beta2-glycoprotein I gene in the generation of anti-beta2-glycoprotein I antibodies in the antiphospholipid syndrome.. 42. 1999
Association of HLA alleles and clinical features in patients with synovitis of recent onset.. 42. 1999
Identification of multiple, differentially expressed messenger RNAs in dermal fibroblasts from patients with systemic sclerosis.. 42. 1999
An immunodominant epitope on DNA topoisomerase I is conformational in nature: heterogeneity in its recognition by systemic sclerosis sera.. 42. 1999
Chlamydia trachomatis nucleic acids can be found in the synovium of some asymptomatic subjects.. 42. 1999
Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera.. 42. 1999
Altered distribution of Fcgamma receptor IIIA alleles in a cohort of Korean patients with lupus nephritis.. 42. 1999
Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody.. 42. 1999
Autoantibodies to RNA polymerases recognize multiple subunits and demonstrate cross-reactivity with RNA polymerase complexes.. 42. 1999
Parathyroid hormone-related proteins is abundant in osteoarthritic cartilage, and the parathyroid hormone-related protein 1-173 isoform is selectively induced by transforming growth factor beta in articular chondrocytes and suppresses generation of extracellular inorganic pyrophosphate.. 41. 1998
The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint.. 41. 1998
Molecular characterization of a CD95 signaling mutant.. 41. 1998
Anticardiolipin IgG subclasses: association of IgG2 with arterial and/or venous thrombosis.. 40. 1997
Human chondrocyte expression of growth-arrest-specific gene 6 and the tyrosine kinase receptor axl: potential role in autocrine signaling in cartilage.. 40. 1997
Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: a mechanism for methotrexate-induced nodulosis in rheumatoid arthritis.. 40. 1997
Fc gammaRIIA polymorphism as a risk factor for invasive pneumococcal infections in systemic lupus erythematosus.. 40. 1997
Levels of soluble Fas/APO-1/CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis.. 38. 1995
Increased frequency of V beta 17-positive T cells in patients with rheumatoid arthritis.. 37. 1994
Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial.. 37. 1994
Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies.. 36. 1993
An organizational model for developing multidisciplinary clinical research in the academic medical center.. 36. 1993
Low-dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a multicenter randomized, double-blind, placebo-controlled trial.. 36. 1993
Analysis of immunoglobulin gamma heavy chain expression in synovial tissue of a patient with rheumatoid arthritis.. 36. 1993
Serum anti-SS-B/La and IgA rheumatoid factor are markers of salivary gland disease activity in primary Sjögren's syndrome.. 35. 1992
Antiphospholipid antibody/lupus anticoagulant workshop.. 35. 1992
A rheumatoid factor from a normal individual encoded by VH2 and V kappa II gene segments.. 35. 1992
Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.. 35. 1992
Serologic studies of monozygotic twins with systemic lupus erythematosus.. 35. 1992
Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience.. 34. 1991
Relationship of clinical features with psychological status in primary fibromyalgia.. 34. 1991
Characteristics of high-titer IgG antiphospholipid antibody in systemic lupus erythematosus patients with and without fetal death.. 33. 1990
Septic arthritis. Staphylococcal induction of chondrocyte proteolytic activity.. 33. 1990
High-dose, pulse intravenous methylprednisolone enhances Fc gamma receptor-mediated mononuclear phagocyte function in systemic lupus erythematosus.. 32. 1989
Pregnancy does not cause systemic lupus erythematosus to worsen.. 32. 1989
Neonatal lupus risk to newborns of mothers with systemic lupus erythematosus.. 31. 1988
Hypocomplementemia with low C1s-C1 inhibitor complex in systemic lupus erythematosus.. 29. 1986
Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus.. 29. 1986
Lupus pregnancy. II. Unusual pattern of hypocomplementemia and thrombocytopenia in the pregnant patient.. 28. 1985
Altered expression of complement receptors as a pathogenetic factor in systemic lupus erythematosus.. 27. 1984
Psychological factors associated with primary fibromyalgia syndrome.. 27. 1984
Application of monoclonal antibodies to the characterization of cells eluted from human articular cartilage. Expression of Ia antigens in certain diseases and identification of an 85-kD cell surface molecule accumulated in the pericellular matrix.. 26. 1983
Total knee arthroplasty in juvenile arthritis.. 26. 1983
Familial systemic lupus erythematosus in males.. 26. 1983
Rheumatology education in United States medical school.. 24. 1981
Manpower and fellowship education in rheumatology, 1980.. 24. 1981
The unproven remedies committee.. 24. 1981
Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders.. 23. 1980
Evidence for the presence of receptors for C3 and IgG Fc on human synovial cells.. 23. 1980
Central nervous system lupus erythematosus. The need for classification.. 22. 1979
Articular cartilage preservation and storage. I. Application of tissue culture techniques to the storage of viable articular cartilage.. 22. 1979
Contrasting patterns of newer histocompatibility determinants in patients with rheumatoid arthritis and systemic lupus erythematosus.. 21. 1978
Immunopathologic studies of rheumatoid arthritis. I. Absence of complement-dependent cytotoxicity of rheumatoid sera for rheumatoid synovial cell cultures.. 21. 1978
Do medical students in the United States learn clinical rheumatology?. 20. 1977
Immunologic observations on 9 sets of twins either concordant or discordant for SLE.. 19. 1976
Cell-mediated immunity in rheumatic diseases. II. Mitogen responses in RA, SLE, and other illnesses: correlation with T- and B-lymphocyte populations.. 18. 1975
Proceedings: Twin studies in systemic lupus erythematosus (SLE).. 18. 1975
Depressed synovial fluid levels of properdin and properdin factor B in patients with rheumatoid arthritis.. 18. 1975
In vitro rabbit articular cartilage organ model. I. Morphology and glycosaminoglycan metabolism.. 17. 1974
In vitro rabbit articular cartilage organ model. II. 35S incorporation in various oxygen tensions.. 17. 1974
Letter: Spleen size in SLE.. 17. 1974
Cellular immunity in rheumatic diseases. I. Rheumatoid arthritis.. 16. 1973
Gonococcal arthritis in two patients with active lupus erythematosus. A diagnostic problem.. 14. 1971
Diplopia as early sign of temporal arteritis. Report of two cases.. 13. 1970
Reply: To PMID 23044629.. 65. 2013
Antiinflammatory strategies, not just B cell depletion, are required for optimal therapy for severe proliferative lupus nephritis: comment on the article by Rovin et al.. 64. 2012
A time capsule for rheumatology.. 58. 2008
What journal citations teach us about rheumatic diseases.. 58. 2008
Does knee malalignment predispose to osteoarthritis? Comment on the articles by Brouwer et al and Hunter et al and the editorial by Sharma.. 56. 2007
Academic rheumatology: not just a man's world.. 52. 2005
Intravenous immunoglobulin and antiphospholipid syndrome: comment on the article by Erkan et al.. 50. 2004
Treatment with gonadotropin-releasing hormone agonists and prevention of multiple gestations in lupus or antiphospholipid syndrome patients undergoing in vitro fertilization: comment on the article by Guballa et al.. 46. 2002
Adoption by lupus patients who are infertile: comment on the article by Guballa et al.. 43. 2000
Entry criteria influence conclusions about rates of flare in lupus pregnancy: comment on the article by Petri et al.. 35. 1992
Malnutrition does not ameliorate systemic lupus erythematosus.. 23. 1980
Absence of ethical discourse in the rheumatology literature: comment on the article by Caplan et al. 2008
B cell therapy with the anti-CD22 monoclonal antibody epratuzumab: comment on the editorial by St. Clair and Tedder. 2006
Eligibility of rheumatoid arthritis patients seen in clinical practice for rheumatoid arthritis clinical trials: comment on the article by Sokka and Pincus. 2003
Vision loss in giant cell arteritis patients treated with alternate-day corticosteroids: comment on the article by Hoffman et al. 2003
Scleroderma in women with silicone breast implants: comment on the article by Sánchez-Guerrero et al. 1995
Genetics of the Hajdu-Cheney syndrome. 1987
Pac-Man phalanx. 1983
Mentors and heroes: the foundation and future of rheumatology. 2007
Summary of the proceedings of the Institute of Medicine workshop, challenges facing the clinical research enterprise: the response of medical specialty and clinical research societies. How the American College of Rheumatology is addressing areas of concern. 2004
Criteria for steroid-sparing ability of interventions in systemic lupus erythematosus: report of a consensus meeting. 2004
If I am not for myself, who will be for me? 2003
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. 1999
Do mouse models reflect the diversity of osteoarthritis in humans?. 64. 2012
Delay in receiving rheumatology care leads to long-term harm.. 62. 2010
Transition.. 62. 2010
The child, grown, becomes independent.. 60. 2009
The link between structural damage and pain in a genetic model of osteoarthritis and intervertebral disc degeneration: a joint misadventure.. 60. 2009
Pay for performance in rheumatology: will we get the carrot or the stick?. 59. 2008
The HLA-DRB1 shared epitope in Caucasians with rheumatoid arthritis: a lesson learned from tic-tac-toe.. 58. 2008
Articulating a justice ethic for rheumatology: A critical analysis of disparities in rheumatic diseases.. 57. 2007
Estrogens and lupus: bubbling cauldron or another overrated Witches' Brew?. 56. 2007
Therapy for giant cell arteritis: can we do better?. 54. 2006
Are we coming to terms with tumor necrosis factor inhibition in pregnancy?. 54. 2006
Journal policies on authorship and disclosures.. 55. 2006
Journal policies on authorship and disclosures.. 54. 2006
Are bone morphogenetic proteins effective inducers of cartilage repair? Ex vivo transduction of muscle-derived stem cells.. 54. 2006
New journal policy regarding registration of clinical trials.. 52. 2005
Genetic markers of treatment response in rheumatoid arthritis.. 50. 2004
Interferon-alpha: a new target for therapy in systemic lupus erythematosus?. 48. 2003
The JAK/STAT pathway in rheumatoid arthritis: pathogenic or protective?. 48. 2003
Urgent care and tight control of rheumatoid arthritis as in diabetes and hypertension: better treatments but a shortage of rheumatologists.. 46. 2002
Atherosclerosis and lupus: a work in progress.. 44. 2001
Issues in cross-cultural research: an overview.. 45. 2001
Rotator cuff disorders: recognition and management among patients with shoulder pain. 2004
Catastrophic antiphospholipid syndrome: where do we stand? 2003
Osteoarthritis: a disease of the joint as an organ. 2012
Update on hip and knee arthroplasty: current state of evidence. 2005
Measuring quality in arthritis care: the Arthritis Foundation's Quality Indicator set for osteoarthritis. 2004
Measuring quality in arthritis care: the Arthritis Foundation's quality indicator set for analgesics. 2004
Quality of care indicators for gout management. 2004
Meta-analysis of dyspepsia and nonsteroidal antiinflammatory drugs. 2003
Human receptors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease. 2001
The role of the chondrocyte in osteoarthritis. 2000

VIVO Weill Cornell Medical College

Arthritis and rheumatism Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)